A randomized phase II trial comparing capecitabine with oxaliplatin or docetaxel as first-line treatment in advanced gastric and gastroesophageal adenocarcinomas

BACKGROUND: A combination of fluoropyrimidines and platinum is widely accepted as the standard first-line treatment for advanced gastric and gastroesophageal adenocarcinomas. However, the benefit compared with platinum-free chemotherapeutic regimens remains controversial. We compared the efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Lu, Zhang, Weihan, Chen, Ye, Leng, Weibing, Gou, Hongfeng, Hu, Jiankun, Qiu, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084035/
https://www.ncbi.nlm.nih.gov/pubmed/33907099
http://dx.doi.org/10.1097/MD.0000000000025493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084035/
https://www.ncbi.nlm.nih.gov/pubmed/33907099
http://dx.doi.org/10.1097/MD.0000000000025493

Ejemplares similares